![]()
31.07.20151536
As non-valvular atrial fibrillation (AF) brings a risk of stroke, oral anticoagulants (OAC) are recommended.
![]()
30.07.20151442
Mitral valve prolapse (MVP) may present with ventricular arrhythmias and sudden cardiac death (SCD) even in the absence of hemodynamic impairment.
![]()
29.07.20151326
Beta-blocker therapy is one of the most commonly prescribed treatments for patients with cardiac conditions. In patients with out-of-hospital cardiac arrest (OHCA) however, recent data suggest prior treatment with beta-blockers could be harmful by lowering the incidence of a shockable presenting rhythm.
![]()
27.07.20151541
Women with Fontan circulation can successfully complete pregnancy, but an increase in cardiac and neonatal morbidity exists, results by French researchers published in the International Journal of Cardiology show.
![]()
24.07.20151367
The FDA and Sanofi/Regeneron announced that the agency has approved alirocumab, a PCSK9 inhibitor, for lowering of LDL in addition to diet and maximally tolerated statin therapy in patients with heterozygous familial hypercholesterolemia or those with clinical atherosclerotic CVD.
![]()
23.07.20151247
Dislipidemia in type 2 diabetes mellitus contributes to arterial endothelial dysfunction and an increased risk of cardiovascular disease.
![]()
22.07.20151428
The drug, to be marketed as Repatha (Amgen), is the first PCSK9 inhibitor to be approved for intensive reduction of LDL, according to a company press release.
